Drug factory · FDA FEI 3002807654

SGS Société Générale de Surveillance SA

Chemin des Aulx 14, Plan-les-Ouates, Switzerland

Switzerland: 1

Problems found, fixed voluntarily at FDA's last inspection, Aug 22, 2023.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

2 drug inspections on record since 2016: 1 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
EravacyclineTests it Tetraphase Pharmaceuticals, Inc. 71773-050, 71773-100

FDA inspection history

EndedResultProgramProblems noted
Aug 22, 2023Problems found, fixed voluntarilyDrug Quality Assurance—
Jan 26, 2016No problems foundDrug Quality Assurance—

Registered with FDA for: analysis.